Literature DB >> 28280077

Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21st century.

Janick Weberpals1, Dianne Pulte2, Lina Jansen1, Sabine Luttmann3, Bernd Holleczek4, Alice Nennecke5, Meike Ressing6,7, Alexander Katalinic8, Maximilian Merz9, Hermann Brenner1,10,11.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28280077      PMCID： PMC5451350          DOI： 10.3324/haematol.2016.157768

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  39 in total

1.  Solitary bone and extramedullary plasmacytoma.

Authors:  Donna M Weber
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

2.  Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.

Authors:  Eirini Katodritou; Evangelos Terpos; Argiris S Symeonidis; Anastasia Pouli; Charikleia Kelaidi; Marie-Christine Kyrtsonis; Maria Kotsopoulou; Sosana Delimpasi; Anna Christoforidou; Nikolaos Giannakoulas; Nora-Athina Viniou; Ekaterini Stefanoudaki; Christina Hadjiaggelidou; Dimitrios Christoulas; Evgenia Verrou; Vassiliki Gastari; Sofia Papadaki; Genovefa Polychronidou; Athina Papadopoulou; Evlambia Giannopoulou; Efstathios Kastritis; Alexandra Kouraklis; Pavlina Konstantinidou; Achilles Anagnostopoulos; Konstantinos Zervas; Meletios A Dimopoulos
Journal:  Am J Hematol       Date:  2014-05-12       Impact factor: 10.047

3.  Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival.

Authors:  Antonio Palumbo; Sara Bringhen; Alessandra Larocca; Davide Rossi; Francesco Di Raimondo; Valeria Magarotto; Francesca Patriarca; Anna Levi; Giulia Benevolo; Iolanda Donatella Vincelli; Mariella Grasso; Luca Franceschini; Daniela Gottardi; Renato Zambello; Vittorio Montefusco; Antonietta Pia Falcone; Paola Omedé; Roberto Marasca; Fortunato Morabito; Roberto Mina; Tommasina Guglielmelli; Chiara Nozzoli; Roberto Passera; Gianluca Gaidano; Massimo Offidani; Roberto Ria; Maria Teresa Petrucci; Pellegrino Musto; Mario Boccadoro; Michele Cavo
Journal:  J Clin Oncol       Date:  2014-01-21       Impact factor: 44.544

Review 4.  Basic issues in estimating and comparing the survival of cancer patients.

Authors:  F Berrino; J Estève; M P Coleman
Journal:  IARC Sci Publ       Date:  1995

5.  Recent cancer survival in Germany: an analysis of common and less common cancers.

Authors:  Lina Jansen; Felipe A Castro; Adam Gondos; Agne Krilaviciute; Benjamin Barnes; Andrea Eberle; Katharina Emrich; Stefan Hentschel; Bernd Holleczek; Alexander Katalinic; Hermann Brenner
Journal:  Int J Cancer       Date:  2014-11-26       Impact factor: 7.396

6.  Standard cancer patient population for age standardising survival ratios.

Authors:  Isabella Corazziari; Mike Quinn; Riccardo Capocaccia
Journal:  Eur J Cancer       Date:  2004-10       Impact factor: 9.162

7.  Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.

Authors:  Milena Sant; Pamela Minicozzi; Morgane Mounier; Lesley A Anderson; Hermann Brenner; Bernd Holleczek; Rafael Marcos-Gragera; Marc Maynadié; Alain Monnereau; Gemma Osca-Gelis; Otto Visser; Roberta De Angelis
Journal:  Lancet Oncol       Date:  2014-07-13       Impact factor: 41.316

8.  Recent improvement in survival of patients with multiple myeloma: variation by ethnicity.

Authors:  Dianne Pulte; Maria Theresa Redaniel; Hermann Brenner; Lina Jansen; Mona Jeffreys
Journal:  Leuk Lymphoma       Date:  2013-09-03

9.  Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups.

Authors:  Dianne Pulte; Maria Theresa Redaniel; Lina Jansen; Hermann Brenner; Mona Jeffreys
Journal:  Haematologica       Date:  2012-08-28       Impact factor: 9.941

10.  Changes in survival rate of multiple myeloma after the introduction of bortezomib: a single institutional experience over 20 years.

Authors:  Manabu Fujisawa; Yasuhito Suehara; Kota Fukumoto; Masami Takeuchi; Kosei Matsue
Journal:  Ann Hematol       Date:  2016-01       Impact factor: 3.673
View more
  3 in total

1.  Prediction of Solitary Plasmacytoma of Bone in Elderly Patients: A Nomogram and a Risk Classification System for Overall Survival.

Authors:  Xi Zhang; Jiahao Yang; Zhuanhua Tian; Youssef Khabir; Dan Wang
Journal:  Biomed Res Int       Date:  2022-06-01       Impact factor: 3.246

Review 2.  Solitary Plasmacytoma.

Authors:  Sara Grammatico; Emilia Scalzulli; Maria Teresa Petrucci
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-08-23       Impact factor: 2.576

Review 3.  Multiple myeloma with central nervous system relapse.

Authors:  Philip A Egan; Patrick T Elder; W Ian Deighan; Sheila J M O'Connor; H Denis Alexander
Journal:  Haematologica       Date:  2020-05-15       Impact factor: 9.941
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.